How Will Big Data Transform Medicine and Transplantation
Thursday July 5, 2018
Tom Bradicich, USA
Vice President and General Manager for Servers, Converged Edge, and IoT Systems, HP Enterprise
How HP Enterprise's Moonshot & Edgeline Systems can be applied to the needs in global transplantation
Vice President and General Manager for Servers, Converged Edge, and IoT Systems, Hewlett Packard Enterprise
Dr. Tom Bradicich is Vice President and General Manager for Servers, Converged Edge, and IoT Systems at Hewlett Packard Enterprise. He heads this global business unit with P&L, worldwide product development, and customer experience ownership. He was an IBM Fellow, Server CTO, R&D VP, and an National Instruments R&D Fellow. Tom has received numerous industry recognitions, co-founded several industry standards, and pioneered the new product categories such as the notebook PC, converged server blade systems, and converged edge systems. He holds several US patents, serves on the dean's advisory board at the University of Florida, and founded the charitable organization sockrelief.com.
Atul Butte, USA
Professor, UCSF School of Medicine
How can we use large data in medicine
Atul Butte, MD, PhD is the inaugural Director of the Institute of Computational Health Sciences (ichs.ucsf.edu) at the University of California, San Francisco, and a Distinguished Professor of Pediatrics. Dr. Butte is also the Executive Director for Clinical Informatics across the six University of California Medical Schools and Medical Centers. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored over 200 publications, with research repeatedly featured in Wired Magazine, the New York Times, and the Wall Street Journal. Dr. Butte was elected into the National Academy of Medicine in 2015, and in 2013, he was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing medical genome sequencing services, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is a principal investigator of three major programs: the California Initiative to Advance Precision Medicine; ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases; and the California Precision Medicine Consortium, helping recruit tens of thousands of participants into President Obama's Precision Medicine Initiative.
Dorry Segev, USA
Associate Vice Chair for Research, Johns Hopkins Medicine
What does large data tell us in Transplantation
Dr. Dorry Segev is an abdominal transplant surgeon focusing on minimally invasive live donor surgery and incompatible organ transplantation. His research uses advanced statistical methods for mathematical modeling and simulation of medical data, analysis of large healthcare datasets, and outcomes research. He has made significant contributions to the field of transplantation including development of a mathematical model to facilitate a nationwide Kidney Paired Donation program in both the US and in Canada. He is an NIH Clinical Research Scholar, American Geriatrics Society Dennis Jahnigen Scholar, National Institute of Aging Paul Beeson Scholar, senior investigator for the Scientific Registry for Transplant Recipients, and Doris Duke Clinical Scientist Development Award recipient for his groundbreaking work in clinical decision-making for renal failure patients over 65. He has authored more than 250 peer-reviewed research articles in journals including New England Journal of Medicine, JAMA, American Journal of Transplantation, Annals of Surgery, Journal of the American Society of Nephrology, and others. He is an Associate Editor for American Journal of Transplantation, American Journal of Kidney Diseases, and Liver Transplantation. His work is regularly featured in widely read media including TIME magazine, the Discovery Channel, US News & World Report, and the New York Times.
Plenary 1 Speakers Revealed!
Improving Patient Outcomes - Organ Donation
July 2, 2018 from 11:30 to 13:00
Rafael Matesanz, Spain
Founder, National Transplant Organization Madrid, Spain
Challenges to improving deceased organ donation - past, present and future
Rafael Matesanz, MD, PhD is a nephrologist. Founder and Director of the Spanish National Transplant Organisation (ONT), since September 1989. Responsible of the so called "Spanish Model". He was General Director of the Spanish National Institute of Health, President of the Transplant Experts Committee of the Council of Europe during more than 8 years, Scientific Director of the Tuscany Transplant Organization (ITALY) for 3 years, President of the Spanish National Transplant Committee for more than 20 years, President of the Iberoamerican Council of Organ Donation and Transplantation from November 2005, Adviser of The Institute of Medicine (IOM) and of the World Health Organization in the field of organ donation and President of the Scientific Committee of the Mutua Madrileña Foundation from June 2014. Director of different Master and Courses on Coordination and Organization of Donation and Transplantation in the Barcelona University, Menéndez Pelayo International University, University of Alicante and Complutense University of Madrid. Director of some publications such as Nefrología, Revista Española de Trasplantes or Transplant Newsletter of the Council of Europe and Transplant Newsletter of Latin-American Region. Author of more than 500 articles in national and international journals and more than 200 chapters of books or monographs about nephrology, organ donation and transplantation and clinical management. Recognitions and awards such as Rey Jaime I of Clinical Medicine, Gran Cruz de la Orden Civil de Sanidad, Recognition Award TTS, Príncipe de Asturias Award on International Cooperation in 2010, Honorary Ambassador of the Mark Spain, Doctor Honoris Causa from different Spanish and Latin American Universities, Gold Medal of the Madrid Town Hall, Award Excellence in Health-Scientific field, Gran Cruz de la Orden del Dos de Mayo.
Carmen Peralta, Spain
Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Molecular therapeutic targets to minimise ischemia reperfusion injury
Currently, Carmen Peralta is IDIBAPS Researcher group leader Experimental Liver Surgery and Liver transplantation, and coordinator of the Consolidated Research Group for the Generalitat of Catalonia (Group for Quality in Research). The research carried out by Carmen Peralta is focused on pharmacological and surgical strategies that protect steatotic and non-steatotic livers against the vulnerability of this type of liver to ischemia-reperfusion injury and regeneration failure associated with hepatic resections and liver transplantation. Protective strategies in reduced-size liver transplantation are also investigated. Our research could improve the postsurgical outcome in liver surgery and could also contribute to a better use of organs for transplantation and consequently, to diminish waiting lists for liver transplantation.
Carmen Peralta received her Ph.D degrees in Health Sciences and has published more than 102 research articles in international journals with high impact factor in the speciality of Organ Transplantation, and the most of them as first or last author. The average impact factor per publication is 8. Carmen Peralta is above the average of citations at international level in the field of liver transplantation and has an H index of 36 in 21 years of research career. She is the inventor of different patents related with organ transplantation and surgery. Carmen Peralta has participated in more than 150 national and international congresses related with organ transplant and is evaluator of research projects and editorial member of international journals related with organ transplantation. In addition, she has participated and participates as leader or partner in 50 national and international projects funded in public calls and research contracts with companies in organ transplantation.
Peter J. Friend, UK
Professor of Transplantation, University of Oxford
Normothermic perfusion – Will it live up to its promise
Peter Friend obtained his medical degree (MB BChir) from the University of Cambridge (Magdalene College). He is a Fellow of the Royal College of Surgeons (Eng) and has a doctoral degree (MD) from the University of Cambridge. After specialist training, he spent a year as Assistant Visiting Professor of Surgery, Indiana University, USA. In 1989, he returned to the UK as Lecturer in Surgery (Honorary Consultant Surgeon), University of Cambridge; he was also Fellow and Director of Studies in Medicine, Magdalene College, Cambridge. In 1999, he was appointed as Professor of Transplantation, University of Oxford (Honorary Consultant Surgeon); he is also Director of the Oxford Transplant Centre and Fellow of Green Templeton College. Peter Friend’s clinical commitments include organ transplantation (kidney, pancreas, intestine) and hepatobiliary surgery. He heads a translational research group and is author of scientific papers and chapters on clinical transplantation, organ perfusion, immunosuppression, monoclonal antibodies, xenotransplantation, and hepatobiliary surgery. He is chairman of the Multivisceral and Composite Tissue Advisory Group to NHSBT and a past-president of the British Transplantation Society
Welcome to Madrid, Spain
Nancy Ascher TTS President & Congress Chair
José Maria Morales Congress Vice-Chair
It is with great pleasure and anticipation that we wish to invite you to the
27th International Congress of The Transplantation Society which will be
held in Madrid, the capital of Spain, from June 30 to July 5, 2018.